Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Piazza

Showing results (211-220 of 309) with videos related to

Pageof 31
Sort By:
European Heart Journal|May 25, 2026
Pulmonary embolism epidemiology: trends, risk factors, comorbidities, and clinical implicationsMarco Zuin, Cecilia Becattini, Frederikus A Klok, et al.
Journal of the American College of Cardiology|May 26, 2022
Call for Formalized Pathways in Vascular Medicine Training: JACC Review Topic of the WeekRobert T Eberhardt, Marc P Bonaca, Hussein Abu Daya, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
Seminars in Thrombosis and Hemostasis|September 17, 2024
Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge GapsAzita H Talasaz, Bridget McGonagle, Mohsen HajiQasemi, et al.
Intensive Care Medicine|December 19, 2023
High and intermediate risk pulmonary embolism in the ICUScott J Millington, Nadia Aissaoui, Emma Bowcock, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: results from a multicenter cohort analysis with external validationRomain Chopard, Laurent Bertoletti, Marc Badoz, et al.
Thrombosis and Haemostasis|September 16, 2021
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO TrialBehnood Bikdeli, Heather Hogan, Ruth B Morrison, et al.
JACC. Advances|December 14, 2023
Effect of Pharmacomechanical Catheter-Directed Thrombolysis on Segmental Artery Occlusions: Insights From the RESCUE TrialRiyaz Bashir, Gregory Piazza, Brian Firth, et al.
Journal of the American College of Cardiology|June 20, 2006
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trialAjay J Kirtane, Gregory Piazza, Sabina A Murphy, et al.
Journal of Thrombosis and Thrombolysis|September 19, 2022
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort studySteve Deitelzweig, Xuemei Luo, Jennifer L Nguyen, et al.
Pageof 31

Showing results (211-220 of 309) with videos related to

Sort By:
Pageof 31
European Heart Journal|May 25, 2026
Pulmonary embolism epidemiology: trends, risk factors, comorbidities, and clinical implicationsMarco Zuin, Cecilia Becattini, Frederikus A Klok, et al.
Journal of the American College of Cardiology|May 26, 2022
Call for Formalized Pathways in Vascular Medicine Training: JACC Review Topic of the WeekRobert T Eberhardt, Marc P Bonaca, Hussein Abu Daya, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
Seminars in Thrombosis and Hemostasis|September 17, 2024
Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge GapsAzita H Talasaz, Bridget McGonagle, Mohsen HajiQasemi, et al.
Intensive Care Medicine|December 19, 2023
High and intermediate risk pulmonary embolism in the ICUScott J Millington, Nadia Aissaoui, Emma Bowcock, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: results from a multicenter cohort analysis with external validationRomain Chopard, Laurent Bertoletti, Marc Badoz, et al.
Thrombosis and Haemostasis|September 16, 2021
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO TrialBehnood Bikdeli, Heather Hogan, Ruth B Morrison, et al.
JACC. Advances|December 14, 2023
Effect of Pharmacomechanical Catheter-Directed Thrombolysis on Segmental Artery Occlusions: Insights From the RESCUE TrialRiyaz Bashir, Gregory Piazza, Brian Firth, et al.
Journal of the American College of Cardiology|June 20, 2006
Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trialAjay J Kirtane, Gregory Piazza, Sabina A Murphy, et al.
Journal of Thrombosis and Thrombolysis|September 19, 2022
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort studySteve Deitelzweig, Xuemei Luo, Jennifer L Nguyen, et al.
Pageof 31